Sandbox Reserved 818: Difference between revisions
From Proteopedia
Jump to navigationJump to search
Lea Clusan (talk | contribs) |
Paul Giroud (talk | contribs) No edit summary |
||
| Line 13: | Line 13: | ||
==Binding of pertussis toxin to its cellular targets== | ==Binding of pertussis toxin to its cellular targets== | ||
After being secreted by the ''Ptl machinery'' (a member of the [http://en.wikipedia.org/wiki/Secretion#Type_IV_secretion_system_.28T4SS_or_TFSS.29 type IV secretion system]), PTX can interact with almost all mammalian cells, which explains the variety of biological activities of the toxin. <br /> | After being secreted by the ''Ptl machinery'' (a member of the [http://en.wikipedia.org/wiki/Secretion#Type_IV_secretion_system_.28T4SS_or_TFSS.29 type IV secretion system]), PTX can interact with almost all mammalian cells, which explains the variety of biological activities of the toxin. <br /> | ||
No specific receptors for PTX have been identified but many cell surface [http://en.wikipedia.org/wiki/Sialoglycoprotein '''sialoglycoproteins'''] are involved in the binding of PTX | No specific receptors for PTX have been identified but many cell surface [http://en.wikipedia.org/wiki/Sialoglycoprotein '''sialoglycoproteins'''] are involved in the binding of PTX | ||
<ref name="Peppler (1988)"> | <ref name="Peppler (1988)"> | ||
Armstrong,G. D.,Howard,L. A. & M S Peppler (1988) Use of glycosyltransferases to restore pertussis toxin receptor activity to asialoagalactofetuin. J. Biol. Chem., 263: 8677-8684. | Armstrong,G. D.,Howard,L. A. & M S Peppler (1988) Use of glycosyltransferases to restore pertussis toxin receptor activity to asialoagalactofetuin. J. Biol. Chem., 263: 8677-8684. | ||
| Line 23: | Line 23: | ||
<br /> | <br /> | ||
PTX binds its target cells through the ''B oligomer'' : ''S2'' and ''S3'' subunits contains at least two '''carbohydrate-binding sites''' | PTX binds its target cells through the ''B oligomer'' : ''S2'' and ''S3'' subunits contains at least two '''carbohydrate-binding sites''' | ||
<ref name="Read (1994)"> | <ref name="Read (1994)"> | ||
Stein, P. E., Boodhoo, A., Armstrong, G. D., Heerze, L. D., Cockle, S. A., Klein, M. H., & Read, R. J. (1994). Structure of a pertussis toxin–sugar complex as a model for receptor binding. Nature Structural & Molecular Biology, 1(9), 591-596. | Stein, P. E., Boodhoo, A., Armstrong, G. D., Heerze, L. D., Cockle, S. A., Klein, M. H., & Read, R. J. (1994). Structure of a pertussis toxin–sugar complex as a model for receptor binding. Nature Structural & Molecular Biology, 1(9), 591-596. | ||
| Line 29: | Line 29: | ||
. The N-terminal regions of these subunits are involved in receptor binding and the C-terminal domains of S2 and S3 adopt a fold found in other carbohydrate-binding proteins [73]. <br /> | . The N-terminal regions of these subunits are involved in receptor binding and the C-terminal domains of S2 and S3 adopt a fold found in other carbohydrate-binding proteins [73]. <br /> | ||
The B oligomer of PTX is involved in some biological activities of the toxin, independently of the enzyme activity. Thus '''Asn105''' in ''S2'' and '''Lys103''' in ''S3'' are important for the mitogenic activity of pertussis toxin on murine T lymphocytes | The B oligomer of PTX is involved in some biological activities of the toxin, independently of the enzyme activity. Thus <scene name='56/568016/Ptx_asn105/1'>'''Asn105'''</scene> in ''S2'' and '''Lys103''' in ''S3'' are important for the mitogenic activity of pertussis toxin on murine T lymphocytes | ||
<ref name="Locht93"> | <ref name="Locht93"> | ||
Lobet, Y., Feron, C., Dequesne, G., Simoen, E., Hauser, P., & Locht, C. (1993). Site-specific alterations in the B oligomer that affect receptor-binding activities and mitogenicity of pertussis toxin. The Journal of experimental medicine, 177(1), 79-87. | Lobet, Y., Feron, C., Dequesne, G., Simoen, E., Hauser, P., & Locht, C. (1993). Site-specific alterations in the B oligomer that affect receptor-binding activities and mitogenicity of pertussis toxin. The Journal of experimental medicine, 177(1), 79-87. | ||
